Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced the completion of the regulatory requirements to allow for marketing of the VivaGel^® condom in New Zealand under the brand Lifestyles^® Dual Protect™.

Starpharma’s commercial partner, Ansell, along with their New Zealand distributor, EBOS Group, plan to launch the Lifestyles^® Dual Protect™ condom in the New Year having obtained market clearance for New Zealand.

Dual Protect™ with VivaGel^® is the world’s first antiviral condom.

Starpharma CEO, Dr Jackie Fairley, said, “We are very pleased to announce this next approval of the VivaGel^® condom for marketing, and look forward to further regulatory acceptances and launches of the product in other regions in the future.”

The New Zealand label for Dual Protect™ will carry the following information:

• Dual Protect™ incorporates a lubricant which contains VivaGel^®
• VivaGel^® has been shown in laboratory studies to inactivate up to 99.9% of HIV, Herpes and HPV which are common viruses that cause STIs.

Lifestyles^® Dual Protect™ condoms are available in Woolworths stores across Australia and regulatory processes are underway in other markets.

Download ASX Announcement: Marketing Clearance for VivaGel® condom in New Zealand ( pdf file, 110kb)